Stull, Stull & Brody Announces Class Action on Behalf of Shareholders of Candela Corporation

Attorney Advertising. Notice is hereby given that a class action has been commenced on behalf of shareholders of Candela Corporation (“Candela” or the “Company”) (Nasdaq: CLZR) for breaches of fiduciary duty and other violations of state law in connection with an agreement by the Company’s Board of Directors to sell all of the Company’s outstanding shares of common stock to Syneron Medical Ltd. (“Syneron”) in a transaction valued at approximately $65 million. Under the terms of the proposed transaction, shareholders of Candela will receive 0.2911 shares of Syneron ordinary shares for each share of Candela owned (the “Exchange Ratio”). Syneron will issue 6.7 million ordinary shares, valuing Candela at approximately $2.84 per share.

If you own common stock of Candela and wish to obtain additional information about this matter, please contact Stull, Stull & Brody at the toll-free number listed below. Stull, Stull & Brody has litigated many class actions for violations of securities laws and breaches of fiduciary duties on behalf of defrauded investors over the past 40 years and has obtained court approval of substantial settlements on numerous occasions.

The current investigation concerns the proposed Exchange Ratio offered to Candela shareholders and the process by which Candela’s Board of Directors is addressing the proposed transaction. The transaction is expected to close by year end. The focus of the investigation is on whether the Candela Board of Directors breached their fiduciary duties to Candela’s shareholders by agreeing to sell the Company at an unfair price.

If you wish to discuss this matter or have any questions concerning this notice or your rights or interests with respect to this matter, please contact Aaron Brody, Esq. at Stull, Stull & Brody by calling 1-800-337-4983 or 1-212-687-7230, or by email to [e-mail] or by writing to Stull, Stull & Brody, 6 East 45th Street, New York, NY 10017.

Attorney advertising. Prior results do not guarantee a similar outcome.